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Abstract 
Objective: To compare baseline demographics and ten-year outcomes of a first episode psychosis 
patient incidence cohort in order to establish whether current youth-focused age-based criteria for 
Early Intervention (EI) services are justified by patient needs. 
 
Methods: Data on first episode psychosis patients from the AESOP-10 longitudinal follow-up study 
were used to compare baseline characteristics, and ten-year clinical, functional, and service use 
outcomes between those patients who would and would not have met age-based criteria for Early 
Intervention Services, in Australia or in the UK.   
 
Results: 58% men and 71% women with first episode psychosis were too old to meet current 
Australian- Early Intervention age entry-criteria (χ2 =9.1, p=0.003); while 21% men and 34% women 
were too old for UK- Early Intervention age-entry criteria (χ2 =11.1, p=0.001). Ten-year clinical and 
functional outcomes did not differ significantly between groups by either Australian- or UK- Early 
Intervention age-entry criteria. Service use was significantly greater among the patients young 
enough to meet Early Intervention age-criteria [Australia: IRR=1.35 (1.19-1.52) p<0.001; UK: 
IRR=1.65 (1.41-1.93) p<0.001].  
  
Conclusions: Current Early Intervention services are gender- and age-inequitable. Large numbers of 
patients with first episode psychosis will not receive Early Intervention care under current service 
provision.  Illness outcomes at ten-years were no worse in first episode psychosis patients who 
presented within the age range for whom Early Intervention has been prioritised, though these 
patients had greater service use. These data provide a rationale to consider extension of Early 
Intervention to all, rather than just to youth.  
  
Introduction  
Specialist early intervention services (EIS) provide intensive support and management for younger 
individuals in the early years following their first psychotic illness. There is notable variability 
internationally in the upper age threshold selected for EI service provision: in Australia, services are 
typically offered up to age 25; in Singapore to age 40. In the UK, 35 years has been the 
recommended upper age cut-off for referrals (DoH, 2001) but recent NICE guidelines recommend 
that early intervention should be available to all, regardless of age (NICE, 2014). 
 
Historically, EI services have been youth-focussed based on several principles: first, the zeitgeist that 
the majority of psychosis presents earlier in life. Second,  prior to EIS development, evidence that 
there was delay among young people with emerging psychosis obtaining early treatment (Lincoln 
and McGorry, 1995), and finally, the theory that those who develop psychosis at a younger age 
suffer greater long-term impairment because the illness interrupts their social, personal and 
scholastic/occupational development (DoH, 2001).  
 
Using data from the UK AESOP-10 study - a longitudinal follow-up of an incidence cohort of first 
episode psychosis patients - this study examined first, the baseline characteristics of first episode 
psychosis (FEP) individuals who would and would not meet current age-based criteria for EIS in 
Australia, or in the UK. Second, it tested the question whether ten-year clinical, functional and 
service use outcomes were worse in those who develop FEP at an age young enough to meet criteria 
for EI provision. It is important to emphasise that the cohort studied was treated in an era prior to 
the establishment of EI services; thus this is not an examination of the effectiveness of EI care. 
Rather, these analyses compare baseline characteristics and ten-year outcomes of all first episode 
psychosis patients in order to establish an evidence base for EI provision by testing the theory that 
those who develop psychosis at a younger age have worse outcomes than those who develop 
psychosis at an older age. 
Methods 
Setting 
This paper is based on data from ÆSOP (Kirkbride et al, 2006) and ÆSOP-10 (Morgan et al, 2014), 
which are incidence and ten-year follow-up studies, respectively, of all individuals with a first 
episode of psychosis presenting for the first time to specialist mental health services in defined 
catchment areas in the UK between 1997 and 1999. Recruitment of ÆSOP cases ended before EI 
services were established in these areas. 
 
Cases 
Within tightly defined geographical areas in London and Nottingham, all cases with first episode of 
psychosis (codes F20–29 and F30–33 in ICD–10 (WHO, 1993)) who presented to specialist services 
were included in the incidence study. The Screening Schedule for Psychosis (Jablensky et al, 1992) 
was used to screen cases who presented to these services for eligibility and completed based on 
information from clinical notes, corroboration from mental health staff and, where possible, by 
interview with the participant.  
 
Inclusion criteria for cases were: aged between 16 and 64 years with a first episode of psychosis and 
resident within the study catchment areas. Exclusion criteria were: evidence of psychotic symptoms 
precipitated by an organic cause; transient psychotic symptoms resulting from acute intoxication as 
defined by ICD–10 (WHO, 1993); previous contacts with mental health services for psychosis; and 
moderate or severe learning difficulties, or an IQ of less than 50 (WHO, 1993). 
 
Follow-up 
Cases were followed-up ten years after first contact with mental health services (detailed in Morgan 
et al (2014). At baseline, 532 incidence cases were identified. Of those, 387 had follow-up outcome 
data and thus made up the core analytic sample for outcome analyses (excluding those who had 
died, emigrated or been excluded, plus those who did not have useable information on clinical 
course and outcome for at least eight years of follow-up). Within our analyses of outcomes, we 
excluded six further cases as they presented to services less than three weeks before EIS were 
launched in the London catchment area.  
 
Measures 
Baseline: Clinical and demographic data were collected from clinical records and, where possible, 
from interview. A shortened version of the Schedules for Clinical Assessment in Neuropsychiatry 
(SCAN version 2; WHO, 1994) was used to assess symptom presence and severity. This was used in 
conjunction with other clinical information (excluding diagnosis) to assign ICD-10 (WHO, 1993) 
psychotic diagnoses within research-team consensus meetings. Diagnoses were made blind to 
ethnicity and diagnosis from the clinical notes, as soon as possible after first contact. The Personal 
and Psychiatric History Schedule (WHO, 1996) was used to determine duration of untreated 
psychosis (DUP), defined as the period from onset of psychosis to first contact with statutory mental 
health services. Onset of psychosis was defined as the presence for one week or more of psychotic 
symptoms, further detailed in Morgan et al (2006).  
 
Follow-up: The WHO Life Chart Schedule (Harrison et al, 2001; Sartorius et al, 1996; Susser et al, 
2000) - designed to assess the long-term course of schizophrenia- was used to collate information at 
follow-up. It comprises four main areas: symptoms; treatment; residence; and work. It was adapted 
to include additional information on service use, including use of prescribed medication over follow-
up. Information was derived for the Life Chart from multiple sources: case notes, interviews with 
cases, and informant information. Key variables have been defined previously elsewhere (Morgan et 
al, 2014). Course of illness was categorised as follows: remission within six months; episodic (no 
episode longer than six months’ duration); continuous (no remission longer than six months’ 
duration); or none of the above. Course type “none of the above” refers to an intermediate illness 
course which was neither episodic not continuous; these individuals experienced both an episode 
that lasted longer than 6 months and a period of remission that lasted longer than 6 months during 
the follow-up. 
 
The Life Chart was also used to record number of inpatient days; mental state at follow-up (in the 
last 30 days; psychotic or not psychotic); history of self-harm over follow-up; lifetime substance 
misuse (present/absent); and percentage of time employed over follow-up (dichotomised into under 
and over 25%). The Life Chart was presented at consensus meetings along with case note 
information so that decisions about all aspects of the Life Chart could be decided upon by consensus. 
The Global Assessment of Function (GAF) disability scale (Endicott et al, 1976) was used to assess 
function at follow-up; higher score indicates better level of general functioning. Treatment 
resistance was defined in line with modified Kane criteria for treatment resistance (Conley and Kelly, 
2001). 
 
Ethics 
Full ethical approval for all aspects of the follow-up was provided by the local research ethics 
committees in South East London and Nottingham. All researchers had substantive or honorary 
contracts with either the South London and Maudsley National Health Service (NHS) Foundation 
Trust or the Nottingham Healthcare NHS Trust, the primary participating service providers. 
 
Analyses 
All data were analysed using STATA 11 (StataCorp, 2009). Age at first presentation to specialist 
services was used to assign subjects to FEP groups by age. Using chi-square tests, we compared 
clinical and sociodemographic characteristics between those ≤35years and those ≥ 36years (UK-EI 
age-criteria); these analyses were repeated for those ≤25years and those ≥ 26years (Australia-EI age-
criteria). 
We compared outcomes in those ≤35years and those ≥ 36years (UK-EI age-criteria) using, as 
appropriate, logistic (binary or multinomial), Poisson, or linear regression analyses. We adjusted 
analyses for gender, ethnicity, centre, and diagnosis to assess whether variations in outcome by age-
group status were accounted for by these variables. Non-normally distributed continuous data were 
analysed using non-parametric bootstrap regressions (ordinary least squares). Bootstrap regressions 
were used as they produce the same coefficients as linear regression (and so are interpreted in the 
same way) but give more robust confidence intervals and therefore a more robust estimate of 
statistical significance. Analyses were repeated for those ≤25years and those ≥ 26years (Australia-EI 
age-criteria). 
 
 
  
Results 
532 incidence cases were identified at baseline and comprised the sample for determining who 
would have been eligible for EI service provision. Demographic characteristics are detailed in Table 
1. Table 2 shows the number and percentage of cases who would and would not have met age-entry 
criteria for EIS in Australia (<=25years); and in the UK (<=35years); by gender, DUP, diagnosis, 
treatment resistance and substance use.  
 
Baseline illness profiles and characteristics 
Australia-EIS age-criteria. Of 532 cases, 196 (36.8%) would have met age entry criteria for EIS in 
Australia (χ2 =9.1, df1, p=0.003) (Table 2). 42% of men were ≤25years, compared with only 29% of 
women aged ≤25 (χ2 =11.0, df1, p=0.001). There was a greater proportion of patients aged≥ 26years 
who had a DUP>2years (19.4% compared to 7.7% in those ≤25years) (χ2 =13.2, df1, p=0.001).  There 
was a non-significant trend for greater proportion of depressive psychoses in the 26+years group 
(χ2=5.8, df2, p=0.06). Treatment resistant illness was significantly more common in the ≤25years 
group (30.5% compared to 16.7% in those≤26years) (χ2 =6.7, df1, p=0.009); as was substance misuse 
group (31.5% compared to 17.8% in those≥26years) (χ2 =10.4, df1, p=0.001) (Table 2). 
 
UK-EIS age-criteria. Of 532 cases, 391 (73.5%) would have met age entry criteria for EIS in UK.  62% 
of men were ≤35years, compared with only 38% of women aged ≤35 (χ2 =11.0, df1, p=0.001) (Table 
2). A total of 80 FEP cases presented with a DUP> 2years and in some services would not have been 
accepted by EIS. Of those ≤ 35years, 11.5% had a DUP over two years, compared to 24.8% of 
those≥36years (χ2 =14.4, df1, p<0.001). Diagnostically, there were significantly higher proportions of 
manic psychoses in those ≤35years, and of depressive psychoses in those≥36years (χ2=11.5, df2, 
p=0.003). There were significantly more cases of treatment resistant illness (χ2 =8.3, df1, p=0.004) 
and of substance misuse (χ2 =26.56, df1, p<0.001) in those ≤35years (Table 2). 
 
Outcomes 
The core analytic sample for analyses of outcomes at follow-up comprised 387 individuals (Morgan 
et al, 2014). For the analyses detailed here, six were excluded who presented less than three weeks 
before the introduction of EIS in the London catchment area for AESOP, giving a total sample of 381. 
Clinical, functional and service use outcomes are shown in Table 3 [Australia-based analyses] and 
Table 4 [UK-based analyses].  Adjusted analyses have been included to provide information about 
how key variables (gender; centre; diagnosis and ethnicity) impact on outcomes; unadjusted 
analyses are reported because they reflect the service use and outcomes of the populations as they 
would be presenting to EIS or other services, but it is important to note that for any given service, 
these outcomes would differ according to the demographics of the population being served.   
 
Clinical Outcomes 
Australia-EIS age-criteria. There were no differences between groups in course of illness (OR= 1.18, 
CI: 0.67-2.08); mental state at follow-up (OR= 1.00, CI: 0.61-1.62); or self-harm (OR= 1.17, CI: 0.63-
2.16)(Table 3).  
UK-EIS age-criteria. There was no difference between groups in course of illness over follow-up, with 
the highest proportion in both groups having a course that was neither episodic nor continuous (OR= 
0.96, CI: 0.51-1.81), nor in mental state at follow-up (OR=1.28, CI: 0.75-2.20). More patients 
≤35years engaged in self- harming behaviour over follow-up than those≥36years (OR=2.88, CI: 1.18-
7.04, p=0.02) (Table 4).  
 
Functional Outcomes  
Australia-EIS age-criteria. Neither GAF disability at follow-up (BMD= -1.19, CI: -5.63-3.24) nor 
employment over follow-up (OR=1.20, CI: 0.70-2.04) significantly differed between groups (Table 3). 
UK-EIS age-criteria. Again, neither GAF disability at follow-up (BMD= -1.85, CI: -6.81-3.11) nor 
employment over follow-up (OR=1.87, CI: 0.96-3.65) significantly differed between groups (Table 4).   
Service Use 
Australia-EIS age criteria. There was a higher number of admissions (IRR=1.35, CI: 1.19-1.52, 
p<0.001) and greater proportion of follow-up in hospital in those ≤25years (BMD=4.02, CI: 1.51-6.54, 
p=0.02)(Table 3).  
UK-EIS age-criteria. Those ≤35years were admitted to hospital over ten-year follow-up more often 
than those ≥36years (incidence rate ratio (IRR) =1.65, CI: 1.41-1.93, p<0.001). Proportion of follow-
up spent in hospital was higher in those ≤35years (bootstrapped mean difference (BMD) =2.88%, CI: 
0.54-5.22, p=0.14)(Table 4).  
 
 
 
 
Discussion 
This study uses data from a large observational cohort of first episode psychosis patients to explore 
the evidence base for prioritisation of early intervention (EI) service provision in first episode 
psychosis.  The first striking finding is that current EI services are gender-inequitable: more than two 
thirds of women in Australia, and one third of women in the UK, are excluded from current EIS 
because they are too old. Evidence that men have an earlier onset of psychosis is well-replicated 
(Rabinowitz et al, 2006), and 20% of women with schizophrenia have illness onset after the fortieth 
year of life (Riecher-Rossler, 2007). Yet there has been an absence of acknowledgement that age 
cut-offs for EI services disproportionately negatively impact on women. This is concerning, given 
recent meta-analytic evidence that recovery rates in psychosis are similar in men and women 
(Jääskeläinen et al, 2013).  
 
Based on this observational incidence cohort of first episode psychosis, current early intervention 
service provision would be available to only 36.8% of FEP patients in Australia, and to 73.5% in the 
UK. These findings concur well with evidence that 55% of FEP patients in Australia present after the 
typical EI service upper age limit of 25years (Selvendra et al, 2014). Similarly, Greenfield and co-
workers (2016) recently described that following the extension of their UK-based EI service to age 
65, 30% of subsequent referrals were aged over 35years (Greenfield et al, 2016). This evidence 
challenges the presently-held misapprehension that psychosis is an illness of young people. In fact, 
epidemiological evidence indicates that FEP presents across the age-span, and that with increasing 
age there are increased relative proportions of females affected (Hafner, 2003).  
 
Duration of untreated psychosis of greater than two years was significantly more common in the 
patients too old to be accepted for EI care in either Australia or the UK. Because these data pre-date 
the establishment of EIS, this finding is not explained by successful earlier detection through 
interventions targeted at the younger age group. Clearly it is not only young people with emerging 
psychosis who are delayed in obtaining early treatment (Lincoln and McGorry, 1995). These findings 
are concerning and suggest delayed help-seeking, and/or less adept detection of psychosis in this 
older age-group. While longer DUP is known to be associated with poorer outcomes, despite longer 
DUP being more common in the older group, outcomes were similar to those in the younger group. 
Various explanations are possible: the association between longer DUP and poorer outcomes at 1-2 
years following FEP is of moderate effect size; studies over longer follow-up periods show mixed 
findings (Marshall et al, 2005). Further, the greater proportion of individuals with treatment 
resistant illness (with associated poorer outcomes) in the younger age group may explains the lack 
of difference in outcomes between groups, despite the difference in DUP.   
 
Clinical and Functional Outcomes 
There was no evidence that younger patients experienced poorer clinical outcomes: neither illness 
course nor likelihood of being psychotic at ten-year follow-up differed between those who were or 
were not below the age cut-offs. Nor was there any support for the hypothesis that patients 
presenting younger had poorer functional outcomes: neither employment nor disability (measured 
by GAF score) - differed between those who would and would not have met criteria for EIS in either 
Australia or UK. These findings indicate that older clients’ clinical and functional needs are at least as 
great as those of younger clients.  
 
Similar outcomes; different service use 
Individuals young enough to meet current criteria for EIS in Australia or in the UK had greater service 
use: patients aged ≤25years spent proportionally longer in hospital during ten-year follow-up; and 
were admitted at a greater rate: number of admissions over time was 35% greater than in those 
≥26years. This may in part be explained by markedly higher rates of comorbid substance use, and 
significantly higher rates of self-harm in the younger FEP group. Additionally, treatment resistant 
illness was significantly more prevalent in the younger FEP group, possibly contributing to the 
observed higher service use.  Yet despite this greater service use, there was no difference in the 
clinical and functional outcomes at follow-up.  
 
Strengths of this study include the epidemiologically robust methods employed in AESOP10; 
previous studies of long-term course and outcome have focused on prevalence samples of patients 
with schizophrenia only (rather than all psychosis), which tend to have an over-representation of 
patients with poorer outcomes. Such studies have often applied an upper age cut-off well below 
65years (reviewed in Morgan et al, 2014), which may artificially perpetuate the idea that FEP is an 
illness only of young people. In AESOP-10, clinical and functional outcomes were considered 
separately. Approximately 40% of patients with a non-affective disorder achieved symptomatic 
recovery (Morgan et al, 2014), in accordance with the rate of 47% reported by Robinson and 
coworkers in their 5-year follow-up of first-episode schizophrenia patients (Robinson et al, 2004). 
Functional recovery was left often achieved: only 22% of AESOP-10 clients were employed at 10-year 
follow-up (Morgan et al, 2014). These recovery rates are in keeping with those reported elsewhere: 
Jääskeläinen and coworkers’ meta-analysis of clinical and social recovery rates in psychosis reported 
median rates of 13.5, with a range of 8% to 20% (Jääskeläinen et al, 2013). 
 
 Several limitations of this study should be acknowledged: first, as with all long-term follow-up 
studies, it is possible that selection or information bias might occur as a result of loss to follow-up/ 
missing data. As detailed in Morgan et al (2014), exhaustive tracing efforts resulted in follow-up of 
over 90% of the cohort, and analyses showed that there was no strong evidence of systematic bias. 
Second, the inferences made about the needs of patients of future EIS extend only to the age group 
of patients included here: 16-64years.  
 
 
Conclusions 
EIS have historically been youth-focussed, based on the premise that psychotic illness interferes at a 
key stage in a young person’s development. We do not dispute that premise, but emphasise that 
psychosis impacts at all stages of life. Interestingly, the use of the term early intervention in 
psychosis has for many come to be synonymous with intervention in youth psychosis: the idea of 
intervening early should not be conflated with intervening in the young.  
 
We recommend that consideration be given internationally to the extension of EIS provision to all on 
the basis of clinical need and gender- and age- equality. A significant proportion of people suffering 
psychotic illness for the first time are currently exempt from specialist services. Discussion is 
warranted about the potential to deliver early intervention to all. Possible service models include 
early intervention services which open to all ages, with a recognition that care offered will need to 
be tailored to different needs of different age groups. Alternatively, in Australia where there has 
been recent growth in youth-focussed mental health services, early intervention in psychosis could 
be managed both within these youth services, and additionally in a dedicated service for psychosis in 
adults over 25years. This would allow EI services to retain their youth focus, while also making 
necessary provision for older FEP patients with the same need for early intervention to optimise 
clinical and functional outcomes.  
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TABLES 
 
Table1: Sociodemographic and clinical characteristics of the entire sample (n=532) 
Characteristics 
 
Number (%) 
London 
Nottingham 
327 (61.5) 
205 (38.5) 
Male 
Female 
308 (57.9) 
224 (42.1) 
Schizophrenia broad 
Manic psychosis 
Depressive psychosis 
385 (72.4) 
71 (13.4) 
76 (14.3) 
White British 
Other White 
Black Caribbean 
Black African 
Asian 
Other 
232 (43.6) 
37 (7.0) 
140 (26.3) 
65 (12.2) 
26 (4.9) 
32 (6.0) 
Age at baseline (years: median; IQR) 29.0 (22.0-36.0) 
DUP (days: median; IQR) 59.5 (15.0-235.0) 
Follow-up (years: median; IQR) 10.4 (9.3- 11.3) 
IQR = interquartile range 
  
 
 
Table 2: Unadjusted analyses comparing characteristics in patients who would and would not have met age-entry criteria for EI services in the UK (≤35years 
or ≥36years), or in Australia (≤25years or ≥26years)  
 Australia-EIS cut-off UK-EIS cut-off 
 ≤25years 
n (%) 
≥26years 
n (%) 
p ≤35years 
n (%) 
≥36years 
n (%) 
p 
Gender (n=532): 
   Male 
   Female 
 
130 (66.3) 
66 (33.7) 
 
178 (53.0) 
158 (47.0) 
 
χ2=9.1, df1, 
p=0.003 
 
243 (62.1) 
148 (37.9) 
 
65 (46.1) 
76 (53.9) 
 
χ2=11.0, df1, 
p=0.001 
DUP (n=532): 
   DUP < 2years 
   DUP > 2years 
 
181 (92.4) 
15 (7.7) 
 
271 (80.7) 
65 (19.4) 
 
χ2=13.2, df1, 
p<0.001 
 
346 (88.5) 
  45 (11.5) 
 
  106 (75.2) 
  35 (24.8) 
 
χ2=14.4, df1, 
p<0.001 
Diagnosis (n=532): 
   Non-affective 
   Manic psychosis 
   Depressive psychosis 
 
147 (75.0) 
30 (15.3) 
19 (9.7) 
 
238 (70.8) 
41 (12.2) 
57 (17.0) 
 
χ2=5.8, df2, 
p=0.056 
 
287 (73.4) 
  59 (15.1) 
  45 (11.5) 
 
98 (69.5) 
12 (8.5) 
31 (22.0) 
 
χ2=11.5, df2, 
p=0.003 
Treatment Resistance (n=257):  
   Non Treatment Resistant 
   Treatment Resistant 
 
66 (69.5) 
29 (30.5) 
 
135 (83.3) 
27 (16.7) 
 
χ2= 6.7, df1, 
p=0.009 
 
146 (74.1) 
   51 (25.9) 
 
55 (91.7) 
  5 (8.3) 
 
χ2= 8.3, df1, 
p=0.004 
Substance misuse (n=419): 
   No 
   Yes 
 
102 (68.5) 
47 (31.5) 
 
222 (82.2) 
48  (17.8) 
 
χ2=10.4, df1, 
p=0.001 
 
222 (71.2) 
  90 (28.8) 
 
102 (95.3) 
    5  (4.7) 
 
χ2=26.6, df1, 
p<0.001 
 
  
Table 3: Differences in service use, clinical and functional outcomes between FEP patients who would and would not have met age-entry criteria for EI 
services in Australia (≤25years or ≥26years)  
 
Outcome 
 
≤25years ≥26years Unadjusted analyses  Adjusted analyses*  
   Odds Ratio (95% CI)  
(unless otherwise indicated) 
P Odds Ratio (95% CI) 
(unless otherwise indicated) 
P 
Number of admissions (n=334) 
(median[IQR]) 
3 (1-6) 2 (1-4) 1.35 (1.19 to 1.52)a <0.001 1.33 (1.18 to 1.51)a <0.001 
Proportion of follow-up days as inpatient 
(n=360) (median[IQR]) 
3.0 (0.7-10.5) 1.9 (0.5-5.9) 4.02 (1.51 to 6.54)b 0.02 3.61 (1.07 to 6.15)b 0.005 
Course of illness (n=340): 
   Continuous  
   Remission within 6 months 
   Episodic  
   None of the above    
 
27 (22.5) 
13 (10.8) 
22 (18.3) 
58 (48.3) 
 
51 (23.2) 
29 (13.2) 
47 (21.4) 
93 (42.3) 
 
- 
0.85 (0.38 to 1.89)  
0.88 (0.44 to 1.76)  
1.18 (0.67 to 2.08)  
 
 
0.69 
0.73 
0.57 
 
- 
1.11 (0.48 to 2.59) 
1.03 (0.49 to 2.16) 
1.25 (0.68 to 2.27) 
 
 
0.80 
0.93 
0.47 
Mental state at follow-up (n=318): 
   Non-psychotic 
   Psychotic 
 
72 (65.4) 
38 (34.6) 
 
136 (65.4) 
72 (34.6) 
 
- 
1.00 (0.61 to 1.62)  
 
 
0.99 
 
- 
0.82 (0.49 to 1.37) 
 
 
0.44 
Self-harm behaviour (n=319): 
   No 
   Yes 
 
93 (82.3) 
20 (17.7) 
 
174 (84.5) 
32 (15.5) 
 
- 
1.17 (0.63 to 2.16)  
 
 
0.62 
 
- 
1.24 (0.66 to 2.34) 
 
 
0.51 
Employment (n=286): 
   Employed less than 25% of follow-up 
   Employed 25% or more of follow-up 
 
70 (69.3) 
31 (30.7) 
 
135 (73.0) 
50 (27.0) 
 
- 
1.20 (0.70 to 2.04)  
 
 
0.51 
 
- 
1.32 (0.75 to 2.32)  
 
 
0.33 
GAF functioning (n=282) (mean; SD) 
 
55.2 (17.6) 56.4 (18.6) -1.19 (-5.63 to 3.24)b 0.60 0.18 (-4.12 to 4.34)b 0.94 
 
IQR = Interquartile range; CI = confidence interval; p = p-value; SD = standard deviation. * Adjusted for baseline gender, centre, diagnosis and ethnicity. 
a IRR Incidence Rate Ratio   b Bootstrapped mean difference 
  
Table 4: Differences in service use, clinical and functional outcomes between FEP patients who would and would not have met age-entry criteria for EI 
services in the UK (≤35years or ≥36years). 
  
Outcome 
 
≤35years ≥36years Unadjusted analyses  Adjusted analyses*  
   Odds Ratio (95% CI)  
(unless otherwise indicated) 
P Odds Ratio (95% CI) 
(unless otherwise indicated) 
P 
Number of admissions (n=334) 
(median[IQR]) 
3 (1-5) 2 (1-3) 1.65 (1.41 to 1.93)a <0.001 1.59 (1.36 to 1.86)a <0.001 
Proportion of follow-up days as inpatient 
(n=360) (median[IQR]) 
2.6 (0.7-8.2) 1.2 (0.5-4.9) 2.88 (0.54 to 5.22)b 0.02 1.80 (-0.61 to 4.21)b 0.14 
Course of illness (n=340): 
   Continuous  
   Remission within 6 months 
   Episodic  
   None of the above    
 
 59 (23.3) 
 31 (12.3) 
 50 (19.8) 
113 (44.7) 
 
19 (21.8) 
11 (12.6) 
19 (21.8) 
38 (43.7) 
 
- 
0.91 (0.38 to 2.15)  
0.85 (0.40 to 1.77)  
0.96 (0.51 to 1.81)  
 
 
0.83 
0.66 
0.89 
 
- 
1.30 (0.52 to 3.28) 
1.12 (0.51 to 2.49) 
1.07 (0.55 to 2.05) 
 
 
0.57 
0.78 
0.85 
Mental state at follow-up (n=318): 
   Non-psychotic 
   Psychotic 
 
151 (64.0) 
 85  (36.0) 
 
57 (69.5) 
25 (30.5) 
 
- 
1.28 (0.75 to 2.20)  
 
 
0.37 
 
- 
1.06 (0.60 to 1.88) 
 
 
0.84 
Self-harm behaviour (n=319): 
   No 
   Yes 
 
194 (80.8) 
 46 (19.2) 
 
73 (92.4) 
 6 (7.59) 
 
- 
2.88 (1.18 to 7.04)  
 
 
0.02 
 
- 
3.37 (1.35 to 8.49) 
 
 
0.01 
Employment (n=286): 
   Employed less than 25% of follow-up 
   Employed 25% or more of follow-up 
 
151 (69.0) 
  68 (31.1) 
 
54 (80.6) 
13 (19.4) 
 
- 
1.87 (0.96 to 3.65)  
 
 
0.07 
 
- 
2.16 (1.06 to 4.37)  
 
 
0.03 
GAF functioning (n=282) (mean; SD) 
 
55.5 (18.7) 57.3 (17.0) -1.85 (-6.81 to 3.11)b 0.46 0.07 (-4.19 to 4.34)b 0.97 
 
 
IQR = Interquartile range; CI = confidence interval; p = p-value; SD = standard deviation. * Adjusted for baseline gender, centre, diagnosis and ethnicity. 
a IRR Incidence Rate Ratio   b Bootstrapped mean difference 
 
